# A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor

> **NCT02336724** · PHASE2 · UNKNOWN · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 88 (actual)

## Conditions studied

- Gastrointestinal Stromal Tumor

## Interventions

- **DRUG:** Famitinib

## Key facts

- **NCT ID:** NCT02336724
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-03
- **Primary completion:** 2018-12
- **Final completion:** 2019-06
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2018-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02336724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02336724, "A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02336724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*